JP2024539281A5 - - Google Patents
Info
- Publication number
- JP2024539281A5 JP2024539281A5 JP2024524636A JP2024524636A JP2024539281A5 JP 2024539281 A5 JP2024539281 A5 JP 2024539281A5 JP 2024524636 A JP2024524636 A JP 2024524636A JP 2024524636 A JP2024524636 A JP 2024524636A JP 2024539281 A5 JP2024539281 A5 JP 2024539281A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- domain
- polypeptide
- sequence encoding
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2115329.1 | 2021-10-25 | ||
| GBGB2115329.1A GB202115329D0 (en) | 2021-10-25 | 2021-10-25 | Chimeric cytokine receptor |
| PCT/GB2022/052707 WO2023073352A1 (en) | 2021-10-25 | 2022-10-24 | Chimeric cytokine receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539281A JP2024539281A (ja) | 2024-10-28 |
| JP2024539281A5 true JP2024539281A5 (enExample) | 2025-04-22 |
Family
ID=78805924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524636A Pending JP2024539281A (ja) | 2021-10-25 | 2022-10-24 | キメラサイトカイン受容体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20260159570A1 (enExample) |
| EP (1) | EP4423117A1 (enExample) |
| JP (1) | JP2024539281A (enExample) |
| GB (1) | GB202115329D0 (enExample) |
| WO (1) | WO2023073352A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024539013A (ja) * | 2021-10-20 | 2024-10-28 | フェイト セラピューティクス，インコーポレイティド | 固形腫瘍における同種異系養子細胞療法のためのエフェクター細胞及びその使用 |
| IL316918A (en) * | 2022-05-09 | 2025-01-01 | Minerva Biotechnologies Corp | Chimeric antigen receptor and IL-18 receptor compositions and methods of using them |
| WO2025209797A1 (en) * | 2024-04-03 | 2025-10-09 | BioNTech SE | Interleukin 18 receptor agents for specific activation of immune effector cells |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011034660A1 (en) | 2009-09-16 | 2011-03-24 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
| GB201206559D0 (en) | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| GB201403972D0 (en) | 2014-03-06 | 2014-04-23 | Ucl Business Plc | Chimeric antigen receptor |
| GB201405845D0 (en) | 2014-04-01 | 2014-05-14 | Ucl Business Plc | Signalling system |
| GB201415347D0 (en) | 2014-08-29 | 2014-10-15 | Ucl Business Plc | Signalling system |
| GB201501936D0 (en) | 2015-02-05 | 2015-03-25 | Ucl Business Plc | Signalling system |
| GB201504840D0 (en) * | 2015-03-23 | 2015-05-06 | Ucl Business Plc | Chimeric antigen receptor |
| GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| US11654158B2 (en) * | 2016-11-17 | 2023-05-23 | 2Seventy Bio, Inc. | TGFBeta signal convertor |
| CA3084551A1 (en) * | 2017-12-14 | 2019-06-20 | Bluebird Bio, Inc. | Daric interleukin receptors |
| EP3848387A4 (en) * | 2018-09-05 | 2022-06-22 | Kong, Seogkyoung | CHIMERIC ANTIGEN RECEPTOR FOR SOLID TUMOR AND T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR |
| MA55911A (fr) * | 2019-05-08 | 2022-03-16 | 2Seventy Bio Inc | Lymphocytes t génétiquement modifiés |
| GB201911187D0 (en) | 2019-08-05 | 2019-09-18 | Autolus Ltd | Receptor |
-
2021
- 2021-10-25 GB GBGB2115329.1A patent/GB202115329D0/en not_active Ceased
-
2022
- 2022-10-24 WO PCT/GB2022/052707 patent/WO2023073352A1/en not_active Ceased
- 2022-10-24 US US18/704,231 patent/US20260159570A1/en active Pending
- 2022-10-24 EP EP22799963.8A patent/EP4423117A1/en active Pending
- 2022-10-24 JP JP2024524636A patent/JP2024539281A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538891A5 (enExample) | ||
| JP2023116674A5 (enExample) | ||
| JP2021035395A5 (enExample) | ||
| AU2025210777A1 (en) | Methods of treating aging-related disorders | |
| RU2015129762A (ru) | ОДНОЛИНКЕРНЫЕ АНТИТЕЛА FabFv И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| JP2010535012A5 (enExample) | ||
| JP2022061992A5 (enExample) | ||
| ES2740930T3 (es) | Bibliotecas de TCR | |
| RU2008134519A (ru) | Связывающие молекулы 3 | |
| JP2019150066A5 (enExample) | ||
| ES2563027T3 (es) | Método para fabricación de moléculas heterodímeras Fc de anticuerpos utilizando efectos de conducción electrostática | |
| RU2017136072A (ru) | Триспецифические связывающие молекулы для лечения вирусной инфекции гепатита в и связанных состояний | |
| JP2017029157A5 (enExample) | ||
| JP2023081303A5 (enExample) | ||
| RU2012149858A (ru) | Получение гетеромультимерных белков | |
| ES2873375T3 (es) | Métodos de cribado de anticuerpos | |
| JP2018529359A5 (enExample) | ||
| RU2011153016A (ru) | Три- или тетраспецифические антитела | |
| Himanen | Ectodomain structures of Eph receptors | |
| RU2012143798A (ru) | Биспецифические антитела | |
| AR083705A1 (es) | Inmunoglobulinas con dominio variable dual y usos de las mismas | |
| JP2019536430A5 (enExample) | ||
| JP2019500848A5 (enExample) | ||
| RU2012101485A (ru) | Биспецифические четырехвалентные антигенсвязывающие белки | |
| JP2020500015A5 (enExample) |